Logo do repositório
 
Publicação

The Role of Immunogenetics in the Host-Parasite Interaction of Chagas Disease: Implications for Personalized Medicine

datacite.subject.fosCiências Médicas
dc.contributor.authorHassnain, Muhammad
dc.contributor.authorBukhari, Syeda Mahnoor
dc.contributor.authorBibi, Tahira
dc.contributor.authorWaheed, Syeda Fakhra
dc.contributor.authorBotelho, Monica C.
dc.contributor.authorAhmad, Waqas
dc.date.accessioned2026-03-09T16:44:55Z
dc.date.available2026-03-09T16:44:55Z
dc.date.issued2025-12-19
dc.description(This article belongs to the Special Issue Advances in Parasitic Neglected Tropical Diseases)
dc.description.abstractChagas disease, caused by the protozoan parasite Trypanosoma cruzi, continues to be a significant global health issue, especially in Latin America, with increasing international prevalence due to migration. Despite advancements in diagnosis and treatment, it remains a neglected tropical disease characterized by significant morbidity and mortality, mainly influenced by the complex interaction between parasite diversity and host immune responses. Importantly, the remarkable genetic diversity of T. cruzi lineages also contributes to clinical heterogeneity, influencing immune evasion, therapeutic responses, and vaccine feasibility. This review analyzes the impact of immunogenetics on host-parasite interactions in Chagas disease and explores its implications for personalized therapy approaches. Recent research, particularly over the last decade, has indicated that processes including antigenic variation, extracellular vesicle-mediated regulation, and disruption of host signaling pathways facilitate parasite persistence. Host genetic variables significantly influence susceptibility, disease development, and treatment outcomes, including changes in Human Leukocyte Antigen (HLA) genes, cytokine gene polymorphisms, and immunogenetic determinants of cardiac pathology. These findings underscore the potential of immunogenetic markers as tools for prognosis and as targets for personalized therapies. However, there are still considerable research deficiencies. Inadequate comprehension of gene-environment interactions, lack of representation of varied populations, and inconsistencies in study design limit the use of immunogenetic findings in therapeutic settings. At present, the concept of personalized medicine in Chagas disease remains largely aspirational, better understood as a framework for precision public health or stratified interventions guided by host immunogenetic and parasite lineage data. Addressing these issues necessitates comprehensive genomic research, mechanistic investigations of host-parasite interactions, and clinical validation of genetic markers. This study emphasizes the necessity of incorporating immunogenetics into personalized patient management strategies based on existing evidence. This integration has the potential to improve diagnosis, enhance treatment efficacy, and inform preventive interventions, thereby advancing personalized therapy for Chagas disease.eng
dc.identifier.citationTrop Med Infect Dis. 2025 Dec 19;11(1):2. doi: 10.3390/tropicalmed11010002
dc.identifier.doi10.3390/tropicalmed11010002
dc.identifier.eissn2414-6366
dc.identifier.pmid41591211
dc.identifier.urihttp://hdl.handle.net/10400.18/11267
dc.language.isoeng
dc.peerreviewedyes
dc.publisherMDPI
dc.relation.hasversionhttps://www.mdpi.com/2414-6366/11/1/2
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectChagas Disease
dc.subjectT. Cruzi
dc.subjectGenetic Polymorphisms
dc.subjectHost–Parasite Interaction
dc.subjectImmune Response
dc.subjectImmunogenetics
dc.subjectPersonalized Medicine
dc.subjectInfecções Sistémicas e Zoonoses
dc.subjectGenómica Funcional e Estrutural
dc.titleThe Role of Immunogenetics in the Host-Parasite Interaction of Chagas Disease: Implications for Personalized Medicineeng
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue2
oaire.citation.startPage2
oaire.citation.titleTropical Medicine and Infectious Disease
oaire.citation.volume11
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
MonicaBotelho_tropicalmed-11-00002-v2.pdf
Tamanho:
1.72 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
4.03 KB
Formato:
Item-specific license agreed upon to submission
Descrição: